Cell-cycle regulators, bcl-2 and NF-κB in Epstein-Barr virus-positive gastric carcinomas.pdfVIP

下载本文档

3
0
约3.81万字
约 8页
2017-04-13 发布于江苏
举报
版权申诉

Cell-cycle regulators, bcl-2 and NF-κB in Epstein-Barr virus-positive gastric carcinomas.pdf

1、本文档共8页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

Cell-cycle regulators, bcl-2 and NF-κB in Epstein-Barr virus-positive gastric carcinomas

INTERNATIONAL JOURNAL OF ONCOLOGY 27: 1265-1272, 2005 Cell-cycle regulators, bcl-2 and NF-KB in Epstein-Barr virus-positive gastric carcinomas MEESOO CHANG14, HYE SEUNG LEE2, EUNJIJUNG2, CHULWOOKIM1, BYUNGLANLEE3 and WOO HO KIM1-2 Department of Pathology, Cancer Research Institute, Department of Anatomy, Seoul National University College of Medicine, 28 Yongon-dong, Seoul 110-799; 4Department of Pathology, Seoul National University Boramae Hospital, 425 shindaebang-dong, Seoul 156-707, Korea Received June 6,2005; Accepted July 14,2005 Abstract. The mechanism by which Epstein-Barr virus (EBV) contributes to the carcinogenesis of gastric mucosa remains unanswered. In this study, the role of cell-cycle regulators (p53, p21, p27, pl6, cyclin Dl , Rb), bcl-2 and NF-KB p65 (Rel A) was evaluated. Immunohistochemistry for these proteins was performed in EBV-positive (n=55) and EBV- negative gastric carcinomas (n=72). The bcl-2 protein by Western blot and EBV transcripts using RT-PCR were studied in cell lines. The p27 loss, pi6 loss, cyclin Dl expression and NF-KB nuclear positivity were more frequent in EBV-positive gastric carcinomas than those in EBV-negative gastric carcinomas, while p53 overexpression seldom occurred in EBV-positive carcinomas (p0.001). EBV-positive gastric carcinoma showed unique p53 immunostaining (hetero- geneous, weak to moderate, focal staining), and rare bcl-2 positivity (1 case). Western blot showed bcl-2 to be irrespective of EBV status in stomach cancer cell lines. However, bcl-2 was highly expressed in EBV-positive lymphoma or EBV- positive lymphoblastoid cell lines. The BARF1 transcript was confirmed in both EBV-positive stomach cancer and EBV-positive lymphoma, suggesting tissue type-specific bcl-2 activation by BARF1. The pathological tumor stage was the only independent prognostic factor. A small size of tumor, pi6 preservation and NF-KB nuclear positivity were associated with a good prognosis in univariate a